Wednesday September 4, 2013 0 commentsDENVER - Kyle Lefkoff, founder and general partner of Boulder Ventures, will lead a keynote breakfast conversation with CEOs of Colorado's premier publicly-traded pharmaceutical companies during the 2013 Rocky Mountain Life Science Investor and Partnering Conference on Sept. 19.
Lefkoff will be joined by Patrick Mahaffey, founder and CEO of Clovis Oncology, and Ron Squarer, CEO of Array BioPharma during the conference's opening at the Ritz-Carlton hotel in Denver.
The conference will also feature a luncheon keynote presentation by Jeff Calcagno, principal, Venture Investments, Johnson & Johnson Development Corp.
"Clovis Oncology and Array BioPharma have been incredibly successful reaching both funding and developmental milestones," Lefkoff said. "This is a great opportunity to hear first-hand from their leadership how they have achieved this success and what they look forward to in the future."
The conference is hosted by the Colorado BioScience Association and will begin Sept. 18 with a reception at the Colorado Governor's Mansion and follow with a full day of company pitch presentations from life science businesses in Colorado, Arizona, Montana, New Mexico and Utah.
For more information and registration details, visit http://www.RockyMtnBioInvest.com.